Breaking News Instant updates and real-time market news.

SIG

Signet Jewelers

$69.56 /

+8.525 (+13.97%)

06:15
06/11/21
06/11
06:15
06/11/21
06:15

Signet Jewelers price target raised to $79 from $68 at Citi

Citi analyst Paul Lejuez raised the firm's price target on Signet Jewelers to $79 from $68 and keeps a Neutral rating on the shares following the company's "very solid" quarter. Signet has benefitted from a strong consumer and stimulus checks but there is reason to believe that company, "with its scale and technological advantages, can take share in the disjointed middle market jewelry segment," Lejuez tells investors in a research note.

  • 16

    Jun

  • 25

    Jun

SIG Signet Jewelers
$69.56 /

+8.525 (+13.97%)

06/10/21 Wells Fargo
Signet Jewelers upgraded to Equal Weight from Underweight at Wells Fargo
05/26/21 Northcoast
Signet Jewelers uniquely positioned to benefit over 12 months, says Northcoast
04/13/21 Wells Fargo
Signet Jewelers price target raised to $57 from $50 at Wells Fargo
01/15/21 Citi
Signet Jewelers price target raised to $45 from $40 at Citi

TODAY'S FREE FLY STORIES

Hot Stocks
Fiserv promotes Guy Chiarello to COO, appoints Suzan Kereere as CGO » 08:38
06/24/21
06/24
08:38
06/24/21
08:38
FISV

Fiserv

$107.37 /

-0.925 (-0.85%)

, V

Visa

$234.66 /

-1.28 (-0.54%)

, OMF

OneMain Holdings

$59.68 /

+0.5 (+0.84%)

Fiserv (FISV) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FISV Fiserv
$107.37 /

-0.925 (-0.85%)

V Visa
$234.66 /

-1.28 (-0.54%)

OMF OneMain Holdings
$59.68 /

+0.5 (+0.84%)

FISV Fiserv
$107.37 /

-0.925 (-0.85%)

07:01 Today MoffettNathanson
Negative sentiment on Payment deal stocks overdone, says MoffettNathanson
06/16/21 Baird
Fiserv likely most consistent earnings grower in coverage group, says Baird
06/07/21 Truist
Fiserv downgraded to Hold from Buy at Truist
06/07/21 Truist
Fiserv downgraded to Hold from Buy at Truist
V Visa
$234.66 /

-1.28 (-0.54%)

06/08/21 Credit Suisse
Visa price target raised to $285 from $280 at Credit Suisse
06/07/21
Fly Intel: Top five analyst upgrades
06/07/21 Barclays
Visa price target raised to $284 from $275 at Barclays
06/07/21 Piper Sandler
Visa upgraded to Overweight from Neutral at Piper Sandler
OMF OneMain Holdings
$59.68 /

+0.5 (+0.84%)

06/22/21 Piper Sandler
Piper Sandler calls OneMain a top pick for 2021, ups target to $73
04/18/21 BMO Capital
OneMain Holdings downgraded to Market Perform from Outperform at BMO Capital
04/15/21 JPMorgan
OneMain Holdings price target lowered to $64 from $65 at JPMorgan
02/11/21 Piper Sandler
OneMain secondary creates buying opportunity, says Piper Sandler
FISV Fiserv
$107.37 /

-0.925 (-0.85%)

V Visa
$234.66 /

-1.28 (-0.54%)

OMF OneMain Holdings
$59.68 /

+0.5 (+0.84%)

  • 30
    Apr
  • 30
    Apr
  • 11
    Feb
  • 10
    Dec
  • 13
    Oct
V Visa
$234.66 /

-1.28 (-0.54%)

FISV Fiserv
$107.37 /

-0.925 (-0.85%)

V Visa
$234.66 /

-1.28 (-0.54%)

FISV Fiserv
$107.37 /

-0.925 (-0.85%)

V Visa
$234.66 /

-1.28 (-0.54%)

Hot Stocks
Castor Maritime announces new charter agreement, delivery of M/T Wonder Formosa » 08:37
06/24/21
06/24
08:37
06/24/21
08:37
CTRM

Castor Maritime

$2.77 /

-0.015 (-0.54%)

Castor Maritime announces…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CTRM Castor Maritime
$2.77 /

-0.015 (-0.54%)

CTRM Castor Maritime
$2.77 /

-0.015 (-0.54%)

CTRM Castor Maritime
$2.77 /

-0.015 (-0.54%)

CTRM Castor Maritime
$2.77 /

-0.015 (-0.54%)

CTRM Castor Maritime
$2.77 /

-0.015 (-0.54%)

Hot Stocks
Iteris awarded $2.7M in contracts from Utah Department of Transportation » 08:37
06/24/21
06/24
08:37
06/24/21
08:37
ITI

Iteris

$6.82 /

+0.04 (+0.59%)

Iteris announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ITI Iteris
$6.82 /

+0.04 (+0.59%)

ITI Iteris
$6.82 /

+0.04 (+0.59%)

03/02/21 Northland
Rekor unlikely to increase offer for Iteris, says Northland
12/08/20 B. Riley Securities
Iteris price target raised to $9 from $8.50 at B. Riley Securities
ITI Iteris
$6.82 /

+0.04 (+0.59%)

ITI Iteris
$6.82 /

+0.04 (+0.59%)

Hot Stocks
Vinco Ventures announces 'spin out' of Emmersive Entertainment Vinco Ventures » 08:37
06/24/21
06/24
08:37
06/24/21
08:37
BBIG

Vinco Ventures

$4.77 /

-0.215 (-4.31%)

Vinco Ventures announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BBIG Vinco Ventures
$4.77 /

-0.215 (-4.31%)

BBIG Vinco Ventures
$4.77 /

-0.215 (-4.31%)

BBIG Vinco Ventures
$4.77 /

-0.215 (-4.31%)

Hot Stocks
Seaspan strengthens partnership with COSCO SHIPPING » 08:37
06/24/21
06/24
08:37
06/24/21
08:37
ATCO

Atlas Corp.

$13.58 /

-0.03 (-0.22%)

Seaspan, a wholly owned…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ATCO Atlas Corp.
$13.58 /

-0.03 (-0.22%)

ATCO Atlas Corp.
$13.58 /

-0.03 (-0.22%)

03/22/21
Atlas Corp. to host virtual investor day
03/22/21
Atlas Corp. to host virtual investor day
03/10/21 B. Riley Securities
Atlas Corp. price target raised to $18 from $16.50 at B. Riley Securities
03/10/21 Citi
Atlas Corp. price target raised to $15 from $11 at Citi
ATCO Atlas Corp.
$13.58 /

-0.03 (-0.22%)

Hot Stocks
Cellectar Biosciences announce election of Dr. Chanan-Khan to board of directors » 08:36
06/24/21
06/24
08:36
06/24/21
08:36
CLRB

Cellectar Biosciences

$1.21 /

+0.02 (+1.68%)

Cellectar Biosciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CLRB Cellectar Biosciences
$1.21 /

+0.02 (+1.68%)

CLRB Cellectar Biosciences
$1.21 /

+0.02 (+1.68%)

06/04/21 Roth Capital
Cellectar Biosciences' Phase 2a results 'highly positive,' says Roth Capital
04/27/21 Roth Capital
Cellectar strengthens IP estate as CLR 131 trial progresses, says Roth Capital
07/01/20 Oppenheimer
Oppenheimer bullish on Cellectar Biosciences, initiates with an Outperform
07/01/20 Oppenheimer
Cellectar Biosciences initiated with an Outperform at Oppenheimer
CLRB Cellectar Biosciences
$1.21 /

+0.02 (+1.68%)

  • 23
    Dec
Hot Stocks
Prothena announces Bristol-Myers opt-in to enter exclusive license for PRX005 » 08:35
06/24/21
06/24
08:35
06/24/21
08:35
PRTA

Prothena

$48.06 /

+2.78 (+6.14%)

, BMY

Bristol-Myers

$65.26 /

-0.68 (-1.03%)

Prothena Corporation…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PRTA Prothena
$48.06 /

+2.78 (+6.14%)

BMY Bristol-Myers
$65.26 /

-0.68 (-1.03%)

PRTA Prothena
$48.06 /

+2.78 (+6.14%)

06/18/21 Jefferies
Jefferies a buyer of Prothena on Biogen's negative Tau disappointment pullback
06/18/21 BofA
BofA upgrades Prothena to Neutral on PRX012 potential following Aduhelm approval
06/18/21 BofA
Prothena upgraded to Neutral from Underperform at BofA
06/15/21 Citi
Prothena price target raised to $57 from $39 at Citi
BMY Bristol-Myers
$65.26 /

-0.68 (-1.03%)

06/18/21 Jefferies
Jefferies a buyer of Prothena on Biogen's negative Tau disappointment pullback
05/05/21 Wells Fargo
Wells sees 'limited impact' on Iovance's lifileucel from Keytruda/Yervoy data
04/30/21
Fly Intel: Top five analyst downgrades
04/30/21 Morgan Stanley
Bristol-Myers downgraded to Equal Weight on pipeline questions at Morgan Stanley
PRTA Prothena
$48.06 /

+2.78 (+6.14%)

BMY Bristol-Myers
$65.26 /

-0.68 (-1.03%)

  • 24
    Mar
BMY Bristol-Myers
$65.26 /

-0.68 (-1.03%)

PRTA Prothena
$48.06 /

+2.78 (+6.14%)

BMY Bristol-Myers
$65.26 /

-0.68 (-1.03%)

BMY Bristol-Myers
$65.26 /

-0.68 (-1.03%)

Hot Stocks
Kura Oncology doses first patient in Phase 1b portion of KOMET-001 trial » 08:35
06/24/21
06/24
08:35
06/24/21
08:35
KURA

Kura Oncology

$21.43 /

-0.1 (-0.46%)

Kura Oncology announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KURA Kura Oncology
$21.43 /

-0.1 (-0.46%)

KURA Kura Oncology
$21.43 /

-0.1 (-0.46%)

05/04/21 Credit Suisse
Kura Oncology assumed with an Outperform at Credit Suisse
04/26/21 Credit Suisse
Kura Oncology assumed with an Outperform at Credit Suisse
02/24/21 Piper Sandler
Kura Oncology price target lowered to $30 from $34 at Piper Sandler
02/24/21 H.C. Wainwright
H.C. Wainwright trims Kura Oncology price target to $43 after Q4 report
KURA Kura Oncology
$21.43 /

-0.1 (-0.46%)

  • 09
    Dec
KURA Kura Oncology
$21.43 /

-0.1 (-0.46%)

General news
Equity futures are higher » 08:35
06/24/21
06/24
08:35
06/24/21
08:35
$ECON

Economic Data

/

+

Equity futures are higher…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

Hot Stocks
Corbus Pharmaceuticals trading resumes  08:35
06/24/21
06/24
08:35
06/24/21
08:35
CRBP

Corbus Pharmaceuticals

$1.98 /

+0.055 (+2.86%)

 
ShowHide Related Items >><<
CRBP Corbus Pharmaceuticals
$1.98 /

+0.055 (+2.86%)

CRBP Corbus Pharmaceuticals
$1.98 /

+0.055 (+2.86%)

10/08/20 H.C. Wainwright
Corbus Pharmaceuticals price target lowered to $3 from $6 at H.C. Wainwright
10/06/20 Roth Capital
Corbus Pharmaceuticals price target lowered to $1.22 from $3 at Roth Capital
09/08/20 Jefferies
Corbus Pharmaceuticals downgraded to Hold from Buy at Jefferies
09/08/20 Oppenheimer
Corbus Pharmaceuticals downgraded to Perform from Outperform at Oppenheimer
CRBP Corbus Pharmaceuticals
$1.98 /

+0.055 (+2.86%)

Hot Stocks
Aeglea BioTherapeutics begins dosing in Phase 1/2 trial of AGLE-177 » 08:34
06/24/21
06/24
08:34
06/24/21
08:34
AGLE

Aeglea BioTherapeutics

$6.56 /

+0.36 (+5.81%)

Aeglea BioTherapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AGLE Aeglea BioTherapeutics
$6.56 /

+0.36 (+5.81%)

AGLE Aeglea BioTherapeutics
$6.56 /

+0.36 (+5.81%)

01/05/21 H.C. Wainwright
Aeglea delays trial enrollment goal by two months, says H.C. Wainwright
12/22/20 Piper Sandler
Aeglea BioTherapeutics named a top pick for 2021 at Piper Sandler
08/10/20 Piper Sandler
Piper Sandler backs Overweight rating on Aeglea BioTherapeutics after Q2 results
AGLE Aeglea BioTherapeutics
$6.56 /

+0.36 (+5.81%)

Hot Stocks
Canadian Pacific: Shippers send letters to STB opposing CN/KCS combination » 08:34
06/24/21
06/24
08:34
06/24/21
08:34
CP

Canadian Pacific

$76.09 /

-0.2419 (-0.32%)

, CNI

Canadian National

$105.34 /

-0.22 (-0.21%)

, KSU

Kansas City Southern

$283.42 /

-0.155 (-0.05%)

Canadian Pacific Railway…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CP Canadian Pacific
$76.09 /

-0.2419 (-0.32%)

CNI Canadian National
$105.34 /

-0.22 (-0.21%)

KSU Kansas City Southern
$283.42 /

-0.155 (-0.05%)

CP Canadian Pacific
$76.09 /

-0.2419 (-0.32%)

06/21/21 Stifel
Canadian Pacific resumed with a Hold at Stifel
05/27/21 Scotiabank
Canadian Pacific price target raised to C$108 from C$96 at Scotiabank
05/26/21 Desjardins
Canadian Pacific price target adjusted to reflect 5-for-1 split at Desjardins
05/25/21 Evercore ISI
Kansas City Southern resumed at In Line from Outperform at Evercore ISI
CNI Canadian National
$105.34 /

-0.22 (-0.21%)

06/21/21 Stifel
Canadian National resumed with a Hold at Stifel
05/28/21 UBS
Canadian National upgraded to Buy from Neutral at UBS
05/28/21 Barclays
Kansas City Southern downgraded to Underweight from Equal Weight at Barclays
05/27/21 Scotiabank
Canadian Pacific price target raised to C$108 from C$96 at Scotiabank
KSU Kansas City Southern
$283.42 /

-0.155 (-0.05%)

06/21/21 Stifel
Canadian Pacific resumed with a Hold at Stifel
06/21/21 Stifel
Canadian National resumed with a Hold at Stifel
05/28/21 UBS
Canadian National upgraded to Buy from Neutral at UBS
05/28/21 Barclays
Kansas City Southern downgraded to Underweight from Equal Weight at Barclays
CP Canadian Pacific
$76.09 /

-0.2419 (-0.32%)

CNI Canadian National
$105.34 /

-0.22 (-0.21%)

KSU Kansas City Southern
$283.42 /

-0.155 (-0.05%)

CP Canadian Pacific
$76.09 /

-0.2419 (-0.32%)

CNI Canadian National
$105.34 /

-0.22 (-0.21%)

KSU Kansas City Southern
$283.42 /

-0.155 (-0.05%)

CP Canadian Pacific
$76.09 /

-0.2419 (-0.32%)

CNI Canadian National
$105.34 /

-0.22 (-0.21%)

KSU Kansas City Southern
$283.42 /

-0.155 (-0.05%)

CP Canadian Pacific
$76.09 /

-0.2419 (-0.32%)

CNI Canadian National
$105.34 /

-0.22 (-0.21%)

KSU Kansas City Southern
$283.42 /

-0.155 (-0.05%)

Hot Stocks
GreenSky announces Ritesh Gupta as COO » 08:34
06/24/21
06/24
08:34
06/24/21
08:34
GSKY

GreenSky

$5.81 /

-0.05 (-0.85%)

GreenSky, announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GSKY GreenSky
$5.81 /

-0.05 (-0.85%)

GSKY GreenSky
$5.81 /

-0.05 (-0.85%)

03/11/21 Citi
GreenSky price target raised to $5 from $4 at Citi
11/16/20 Citi
GreenSky price target lowered to $3.50 from $4 at Citi
11/06/20 Wolfe Research
GreenSky initiated with an Underperform at Wolfe Research
11/05/20 Citi
GreenSky assumed with a Sell at Citi
GSKY GreenSky
$5.81 /

-0.05 (-0.85%)

Recommendations
SM Energy price target raised to $39 from $19 at Stifel » 08:33
06/24/21
06/24
08:33
06/24/21
08:33
SM

SM Energy

$24.20 /

+1.19 (+5.17%)

Stifel analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SM SM Energy
$24.20 /

+1.19 (+5.17%)

SM SM Energy
$24.20 /

+1.19 (+5.17%)

06/10/21 RBC Capital
SM Energy downgraded to Sector Perform at RBC Capital on valuation
06/10/21 RBC Capital
SM Energy downgraded to Sector Perform from Outperform at RBC Capital
06/03/21 Barclays
SM Energy price target raised to $9 from $5 at Barclays
03/09/21 Wells Fargo
Wells Fargo upgrades Whiting Petroleum to Overweight, cuts Range to Equal Weight
SM SM Energy
$24.20 /

+1.19 (+5.17%)

Hot Stocks
Integra LifeSciences CEO to step down to accept role of CEO of GE Healthcare » 08:33
06/24/21
06/24
08:33
06/24/21
08:33
IART

Integra LifeSciences

$70.91 /

+0.52 (+0.74%)

Integra LifeSciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IART Integra LifeSciences
$70.91 /

+0.52 (+0.74%)

IART Integra LifeSciences
$70.91 /

+0.52 (+0.74%)

04/29/21 Wells Fargo
Integra LifeSciences price target raised to $74 from $68 at Wells Fargo
04/29/21 Oppenheimer
Integra LifeSciences price target raised to $88 from $79 at Oppenheimer
04/29/21 Citi
Integra LifeSciences price target raised to $78 from $70 at Citi
04/28/21 Piper Sandler
Integra LifeSciences Q2 outlook a negative surprise, says Piper Sandler
IART Integra LifeSciences
$70.91 /

+0.52 (+0.74%)

Hot Stocks
SG Blocks subsidiary acquires development parcel in Atlanta with partnership » 08:33
06/24/21
06/24
08:33
06/24/21
08:33
SGBX

SG Blocks

$5.06 /

+0.155 (+3.16%)

SG Blocks announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SGBX SG Blocks
$5.06 /

+0.155 (+3.16%)

SGBX SG Blocks
$5.06 /

+0.155 (+3.16%)

Recommendations
Eli Lilly price target raised to $250 from $235 at Cowen » 08:29
06/24/21
06/24
08:29
06/24/21
08:29
LLY

Eli Lilly

$217.08 /

-4.51 (-2.04%)

, BIIB

Biogen

$371.82 /

-2.77 (-0.74%)

Cowen analyst Steve Scala…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LLY Eli Lilly
$217.08 /

-4.51 (-2.04%)

BIIB Biogen
$371.82 /

-2.77 (-0.74%)

LLY Eli Lilly
$217.08 /

-4.51 (-2.04%)

06/15/21 JPMorgan
Eli Lilly price target raised to $260 from $240 at JPMorgan
06/14/21 Goldman Sachs
Eli Lilly price target raised to $270 from $252 at Goldman Sachs
06/08/21 Baird
Baird upgrades Biogen to Neutral after 'fatal blow' to bear thesis
06/07/21 BofA
BofA upgrades Biogen to Neutral with $400 price target after Aduhelm approved
BIIB Biogen
$371.82 /

-2.77 (-0.74%)

06/18/21
Fly Intel: Top five analyst upgrades
06/18/21 Jefferies
Jefferies a buyer of Prothena on Biogen's negative Tau disappointment pullback
06/18/21 BofA
BofA upgrades Prothena to Neutral on PRX012 potential following Aduhelm approval
06/18/21 Piper Sandler
Biogen upgraded to Overweight from Neutral at Piper Sandler
LLY Eli Lilly
$217.08 /

-4.51 (-2.04%)

BIIB Biogen
$371.82 /

-2.77 (-0.74%)

LLY Eli Lilly
$217.08 /

-4.51 (-2.04%)

BIIB Biogen
$371.82 /

-2.77 (-0.74%)

LLY Eli Lilly
$217.08 /

-4.51 (-2.04%)

BIIB Biogen
$371.82 /

-2.77 (-0.74%)

LLY Eli Lilly
$217.08 /

-4.51 (-2.04%)

BIIB Biogen
$371.82 /

-2.77 (-0.74%)

Hot Stocks
Amazon and Asmodee file joint lawsuit against counterfeiters » 08:28
06/24/21
06/24
08:28
06/24/21
08:28
AMZN

Amazon.com

$3,503.79 /

+1.79 (+0.05%)

Amazon and Asmodee…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMZN Amazon.com
$3,503.79 /

+1.79 (+0.05%)

AMZN Amazon.com
$3,503.79 /

+1.79 (+0.05%)

04:56 Today Piper Sandler
Amazon Prime Day sales rose 13% over last year, says Piper Sandler
06/22/21 Truist
Wayfair's clearance event looks to capitalize on Prime Day effects, says Truist
06/17/21 Tigress Financial
Amazon shares going to $4,370 in 12 months, says Tigress Financial
06/16/21 JPMorgan
JPMorgan values Amazon Prime at $1,000 per year, 8.5 times actual price
AMZN Amazon.com
$3,503.79 /

+1.79 (+0.05%)

AMZN Amazon.com
$3,503.79 /

+1.79 (+0.05%)

AMZN Amazon.com
$3,503.79 /

+1.79 (+0.05%)

AMZN Amazon.com
$3,503.79 /

+1.79 (+0.05%)

Hot Stocks
Aleafia Health expands edibles portfolio with Salted Caramel Pretzel Bites » 08:28
06/24/21
06/24
08:28
06/24/21
08:28
ALEAF

Aleafia Health

$0.32 /

-0.0008 (-0.25%)

Aleafia Health announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALEAF Aleafia Health
$0.32 /

-0.0008 (-0.25%)

ALEAF Aleafia Health
$0.32 /

-0.0008 (-0.25%)

03/10/21 Cantor Fitzgerald
Aleafia Health initiated with a Neutral at Cantor Fitzgerald
ALEAF Aleafia Health
$0.32 /

-0.0008 (-0.25%)

ALEAF Aleafia Health
$0.32 /

-0.0008 (-0.25%)

Hot Stocks
Novan announces inclusion in Russell Microcap Index » 08:26
06/24/21
06/24
08:26
06/24/21
08:26
NOVN

Novan

$10.48 /

+0.1 (+0.96%)

Novan announced that as…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NOVN Novan
$10.48 /

+0.1 (+0.96%)

NOVN Novan
$10.48 /

+0.1 (+0.96%)

06/17/21 Needham
Verrica Pharmaceuticals's Ycanth offers superior efficacy to Novan, says Needham
06/14/21 H.C. Wainwright
Novan price target raised to $28 from $20 at H.C. Wainwright
06/11/21 Roth Capital
Novan price target raised to $40 from $26 at Roth Capital
04/22/21
Fly Intel: Top five analyst initiations
  • 17
    Jun
NOVN Novan
$10.48 /

+0.1 (+0.96%)

Technical Analysis
DJ Transportation Average: Pivot points » 08:25
06/24/21
06/24
08:25
06/24/21
08:25
$DJT

DJ Transportation Average

/

+

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$DJT DJ Transportation Average
/

+

Technical Analysis
DJ Utility Average: Pivot points » 08:25
06/24/21
06/24
08:25
06/24/21
08:25
$DJU

DJ Utility Average

/

+

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$DJU DJ Utility Average
/

+

Conference/Events
PerkinElmer to hold virtual investor and analyst day » 08:25
06/24/21
06/24
08:25
06/24/21
08:25
PKI

PerkinElmer

$154.69 /

+1.42 (+0.93%)

Virtual Investor and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PKI PerkinElmer
$154.69 /

+1.42 (+0.93%)

PKI PerkinElmer
$154.69 /

+1.42 (+0.93%)

06/15/21 Wolfe Research
PerkinElmer upgraded to Outperform from Peer Perform at Wolfe Research
02/03/21 Citi
PerkinElmer price target raised to $155 from $150 at Citi
01/07/21 Piper Sandler
Oxford Immunotec downgraded to Neutral from Overweight at Piper Sandler
01/07/21 Wells Fargo
PerkinElmer upgraded to Overweight from Equal Weight at Wells Fargo
PKI PerkinElmer
$154.69 /

+1.42 (+0.93%)

PKI PerkinElmer
$154.69 /

+1.42 (+0.93%)

PKI PerkinElmer
$154.69 /

+1.42 (+0.93%)

Conference/Events
Oncternal Therapeutics management to meet virtually with Northland » 08:25
06/24/21
06/24
08:25
06/24/21
08:25
ONCT

Oncternal Therapeutics

$5.20 /

+0.01 (+0.19%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ONCT Oncternal Therapeutics
$5.20 /

+0.01 (+0.19%)

ONCT Oncternal Therapeutics
$5.20 /

+0.01 (+0.19%)

04/06/21 Oppenheimer
Opco starts Oncternal at Outperform on 'compelling' lead asset data
04/06/21 Oppenheimer
Oncternal Therapeutics initiated with an Outperform at Oppenheimer
03/30/21
Fly Intel: Top five analyst initiations
03/30/21 Brookline
Oncternal Therapeutics initiated with a Buy at Brookline
ONCT Oncternal Therapeutics
$5.20 /

+0.01 (+0.19%)

  • 18
    Nov
  • 28
    Aug
ONCT Oncternal Therapeutics
$5.20 /

+0.01 (+0.19%)

ONCT Oncternal Therapeutics
$5.20 /

+0.01 (+0.19%)

Conference/Events
UBS quantitative analyst to hold analyst/industry conference call » 08:25
06/24/21
06/24
08:25
06/24/21
08:25

Analysts provide Quant…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.